Consumer & Categories
The Dividend of 'Lethal Big Wusu' Fades, Chongqing Brewery Hits Growth Bottleneck
Like the foam in beer, the secondary market seems to have overly high expectations for Chongqing Brewery's story. The previous one was the hepatitis B vaccine, and this time it's the 'premiumization transformation'. In the first half of 2022, the company's gross margin declined and its market value halved, as the growth of its high-end products, especially the Wusu brand, slowed down.
李平